Testini M, Rosato L, Avenia N, Basile F, Portincasa P, Piccinni G, Lissidini G, Biondi A, Gurrado A, Nacchiero M
University of Bari, Bari, Italy.
Transplant Proc. 2007 Jan-Feb;39(1):225-30. doi: 10.1016/j.transproceed.2006.10.192.
We compared the surgical outcomes in patients undergoing bilateral thyroid surgery with or without parathyroid gland autotransplantation (PTAT).
One thousand three hundred nine patients underwent surgery for treatment of various thyroid diseases at three Academic Departments of General Surgery and one Endocrine-Surgical Unit throughout Italy. A nonviable gland or difficulties in dissection of the parathyroid glands were encountered in 160 (13.7%) patients. The subjects were divided into two groups: (1) patients undergoing PTAT during thyroidectomy (n = 79) versus (2) control group (n = 81), patients not undergoing PTAT.
Clinical manifestations occurred in 5.0% of PTAT patients and in 13.6% of control patients (P = NS). Total postoperative hypocalcemia was less among PTAT than control patients (17.7% and 48.1%, respectively; P = .0001). There was no significant difference between the two groups in terms of definitive hypocalcemia (0% vs 2.5% in PTAT and control, respectively). Transient postoperative hypocalcemia was less among PTAT than controls (17.7% vs 45.7%; P = .0002). PTAT was associated with decreased occurrence of hypocalcemia in the two subgroups of patients operated for benign euthyroid disease (P < .0001), as compared with the control group.
PTAT is an effective procedure to reduce the incidence of permanent hypoparathyroidism. Transient hypoparathyroidism appears to not be influenced by PTAT. Moreover, we observed that damage to one parathyroid gland has more side effects (ie, transient hypocalcemia) among patients who were preoperatively at low rather than at high risk of postoperative hypocalcemia.
我们比较了接受双侧甲状腺手术且进行或未进行甲状旁腺自体移植(PTAT)患者的手术结果。
1309例患者在意大利三个普通外科教研室和一个内分泌外科单元接受了各种甲状腺疾病的手术治疗。160例(13.7%)患者术中遇到甲状旁腺无活力或解剖困难。将患者分为两组:(1)甲状腺切除术中进行PTAT的患者(n = 79)与(2)对照组(n = 81),即未进行PTAT的患者。
PTAT组患者中5.0%出现临床表现,对照组患者中13.6%出现临床表现(P = 无显著性差异)。PTAT组术后总低钙血症发生率低于对照组(分别为17.7%和48.1%;P = 0.0001)。两组在确定性低钙血症方面无显著差异(PTAT组和对照组分别为0%和2.5%)。PTAT组术后短暂性低钙血症发生率低于对照组(17.7%对45.7%;P = 0.0002)。与对照组相比,PTAT与接受良性甲状腺功能正常疾病手术的两个亚组患者低钙血症发生率降低相关(P < 0.0001)。
PTAT是降低永久性甲状旁腺功能减退发生率的有效方法。短暂性甲状旁腺功能减退似乎不受PTAT影响。此外,我们观察到,在术前术后低钙血症风险低而非高的患者中,甲状旁腺单腺损伤有更多副作用(即短暂性低钙血症)。